Going Beyond "trial-and-error" in Psychiatric Treatments: OPTiMiSE-ing the Treatment of First Episode of Schizophrenia

被引：6
|
作者：
Arango, Celso [1 ]
Kapur, Shitij [2 ]
Kahn, Rene S. [3 ]
机构：
[1] Univ Complutense, Hosp Gen Univ Gregorio Maranon, Sch Med, Child & Adolescent Psychiat Dept,IiSGM,CIBERSAM, E-28040 Madrid, Spain
[2] Kings Coll London, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England
[3] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, Utrecht, Netherlands
来源：
SCHIZOPHRENIA BULLETIN | 2015年 / 41卷 / 03期
关键词：
D O I：
10.1093/schbul/sbv026
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
[No abstract available]
引用
收藏
页码：546 / 548
页数：3
相关论文
共 50 条
  • [41] Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients
    Chen Lin
    Ke Chen
    Jianjin Yu
    Wei Feng
    Weihong Fu
    Fude Yang
    Xiangyang Zhang
    Dachun Chen
    BMC Psychiatry, 21
  • [42] Medication strategies in first onset schizophrenia: A randomized trial of effectiveness of short versus sustained antipsychotic treatment and quality of life in first episode psychosis preliminary findings: Incidence, compliance and early course
    Wunderink, L
    Nienhuis, FJ
    Wiersma, D
    van den Bosch, RJ
    Bruggeman, R
    Faber, G
    van der Linde, J
    Noorthoorn, E
    Slooff, CJ
    Vlaminck, P
    van der Werf, D
    de Wit, P
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 307 - 307
  • [43] Relapse Prevention in First-Episode Schizophrenia-Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia
    Gaebel, Wolfgang
    Riesbeck, Mathias
    Woelwer, Wolfgang
    Klimke, Ansgar
    Eickhoff, Matthias
    von Wilmsdorff, Martina
    Lemke, Matthias
    Heuser, Isabella
    Maier, Wolfgang
    Huff, Wolfgang
    Schmitt, Andrea
    Sauer, Heinrich
    Riedel, Michael
    Klingberg, Stefan
    Koepcke, Wolfgang
    Ohmann, Christian
    Moeller, Hans-Juergen
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (02) : 205 - 218
  • [44] Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial
    Zhang, Cheng
    Yuan Yanbo
    Xue, Han
    Lei, Yang
    Xin, Zeng
    Yang Fude
    Zheng, Lu
    Wang Chuanyue
    Hong, Deng
    Zhao Jingping
    Xiang Yu-Tao
    Correll, Christoph U.
    Xin, Yu
    PSYCHIATRY RESEARCH, 2019, 273 : 631 - 640
  • [45] RESULT OF THE NEUROCOM TRIAL: THE EFFECT OF COMPUTER-ASSISTED COGNITIVE TRAINING COMBINED WITH A PSYCHOSOCIAL TREATMENT PROGRAMME ON COGNITION AND DAILY-LIFE COMPETENCIES OF FIRST-EPISODE SCHIZOPHRENIA PATIENTS
    Vesterager, Lone
    Olsen, Birthe
    Melau, Marianne
    Krarup, Gertrud
    Christensen, Torben
    Nordentoft, Merete
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 513 - 514
  • [46] Assertive Community Treatment as Part of Integrated Care Versus Standard Care: A 12-Month Trial in Patients With First- and Multiple-Episode Schizophrenia Spectrum Disorders Treated With Quetiapine Immediate Release (ACCESS Trial)
    Lambert, Martin
    Bock, Thomas
    Schoettle, Daniel
    Golks, Dietmar
    Meister, Klara
    Rietschel, Liz
    Bussopulos, Alexandra
    Frieling, Marietta
    Schoedlbauer, Michael
    Burlon, Marc
    Huber, Christian G.
    Ohm, Gunda
    Pakrasi, Manoshi
    Chirazi-Stark, Michael Sadre
    Naber, Dieter
    Schimmelmann, Benno G.
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (10) : 1313 - 1323
  • [47] Negative symptoms, anxiety, and depression as mechanisms of change of a 12-month trial of assertive community treatment as part of integrated care in patients with first- and multi-episode schizophrenia spectrum disorders (ACCESS I trial)
    Stefanie J. Schmidt
    Matthias Lange
    Daniel Schöttle
    Anne Karow
    Benno G. Schimmelmann
    Martin Lambert
    European Archives of Psychiatry and Clinical Neuroscience, 2018, 268 : 593 - 602
  • [48] Negative symptoms, anxiety, and depression as mechanisms of change of a 12-month trial of assertive community treatment as part of integrated care in patients with first- and multi-episode schizophrenia spectrum disorders (ACCESS I trial)
    Schmidt, Stefanie J.
    Lange, Matthias
    Schoettle, Daniel
    Karow, Anne
    Schimmelmann, Benno G.
    Lambert, Martin
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2018, 268 (06) : 593 - 602
  • [49] ASSERTIVE COMMUNITY TREATMENT (ACT) AS PART OF INTEGRATED CARE VERSUS STANDARD CARE: A 12-MONTH TRIAL IN PATIENTS WITH FIRST- AND MULTIPLE-EPISODE SCHIZOPHRENIA-SPECTRUM DISORDERS TREATED WITH QUETIAPINE IR (ACCESS TRIAL)
    Lambert, Martin
    Naber, Dieter
    Schimmelmann, Benno
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 408 - 408
  • [50] REMISSION, METACOGNITIVE PROCESSES AND QUALITY OF LIFE - OUTCOMES FROM OPUS TRIAL. A 10 YEAR FOLLOW-UP OF A RANDOMIZED MULTI-CENTER TRIAL OF INTENSIVE EARLY INTERVENTION VS. STANDARD TREATMENT FOR PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA SPECTRUM DISORDER
    Austin, Stephen
    Secher, R. S.
    Hagen, R.
    Mors, O.
    Nordentoft, Merete
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 258 - 258
12345